| abstract |
The present invention relates to compounds of formula (I) (wherein the chemical formula is to be inserted here as in the written summary), as well as tautomers, isomers and esters of the compounds, and the pharmacology of the compounds Provided salts, solvates and prodrugs, wherein R, R 1 , X, Y, Z, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R Each of 8 , R 9 , R 18 , R 19 and n is independently selected and is as defined herein. Compositions comprising such compounds are also provided. The compounds of the present invention are effective as inhibitors of HCV and are effective alone or in combination with other therapeutic agents in the treatment or prevention of diseases or disorders such as viral infections and virus-related disorders. |